304 related articles for article (PubMed ID: 6622516)
1. Calmodulin antagonists enhance calcium binding to calmodulin.
Inagaki M; Tanaka T; Hidaka H
Pharmacology; 1983; 27(3):125-9. PubMed ID: 6622516
[TBL] [Abstract][Full Text] [Related]
2. Hydrophobic interaction of the Ca2+-calmodulin complex with calmodulin antagonists. Naphthalenesulfonamide derivatives.
Tanaka T; Ohmura T; Hidaka H
Mol Pharmacol; 1982 Sep; 22(2):403-7. PubMed ID: 7144734
[TBL] [Abstract][Full Text] [Related]
3. Calmodulin antagonists' binding sites on calmodulin.
Tanaka T; Ohmura T; Hidaka H
Pharmacology; 1983; 26(5):249-57. PubMed ID: 6304789
[TBL] [Abstract][Full Text] [Related]
4. Two types of calmodulin antagonists: a structurally related interaction.
Inagaki M; Hidaka H
Pharmacology; 1984; 29(2):75-84. PubMed ID: 6089236
[TBL] [Abstract][Full Text] [Related]
5. Evidence for calmodulin inter-domain compaction in solution induced by W-7 binding.
Osawa M; Kuwamoto S; Izumi Y; Yap KL; Ikura M; Shibanuma T; Yokokura H; Hidaka H; Matsushima N
FEBS Lett; 1999 Jan; 442(2-3):173-7. PubMed ID: 9928996
[TBL] [Abstract][Full Text] [Related]
6. Symmetric covalent linkage of N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7) results in novel derivatives with increased inhibitory activities against calcium/calmodulin complex.
Yokokura H; Osawa M; Inoue T; Umezawa I; Naito Y; Ikura M; Hidaka H
Drug Des Discov; 1999 Nov; 16(3):203-16. PubMed ID: 10624566
[TBL] [Abstract][Full Text] [Related]
7. H-NMR studies of calmodulin: the effect of W-7 (N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide) and Ca2+ on conformational changes of calmodulin.
Sutoo D; Akiyama K; Fujii N; Matsushita K
Biochim Biophys Acta; 1986 Sep; 873(1):156-60. PubMed ID: 3741880
[TBL] [Abstract][Full Text] [Related]
8. 1H-NMR studies of calmodulin: the modifying effect of W-7 (N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide) on the calcium-induced conformational changes of calmodulin.
Akiyama K; Sutoo D
Jpn J Pharmacol; 1988 Oct; 48(2):157-64. PubMed ID: 3210442
[TBL] [Abstract][Full Text] [Related]
9. Possible role of calmodulin in the control of lysosomal enzyme release from human polymorphonuclear leukocytes.
Marone G; Poto S; Columbo M; Giugliano R; Genovese A; Condorelli M
J Pharmacol Exp Ther; 1984 Dec; 231(3):678-84. PubMed ID: 6502522
[TBL] [Abstract][Full Text] [Related]
10. Ca2+-bound calmodulin forms a compact globular structure on binding four trifluoperazine molecules in solution.
Matsushima N; Hayashi N; Jinbo Y; Izumi Y
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):211-5. PubMed ID: 10727421
[TBL] [Abstract][Full Text] [Related]
11. Antagonists of calcium fluxes and calmodulin block activation of the p21-activated protein kinases in neutrophils.
Lian JP; Crossley L; Zhan Q; Huang R; Coffer P; Toker A; Robinson D; Badwey JA
J Immunol; 2001 Feb; 166(4):2643-50. PubMed ID: 11160327
[TBL] [Abstract][Full Text] [Related]
12. Activation of bovine rod outer segment phosphatidylinositol-4,5-bisphosphate phospholipase C by calmodulin antagonists does not depend on calmodulin.
Gehm BD; Pinke RM; Laquerre S; Chafouleas JG; Schultz DA; Pepperl DJ; McConnell DG
Biochemistry; 1991 Nov; 30(47):11302-6. PubMed ID: 1659898
[TBL] [Abstract][Full Text] [Related]
13. Stimulatory effect of calmodulin antagonists on phospholipid base-exchange reactions in rabbit platelet membranes.
Morikawa S; Taniguchi S; Mori H; Fujii K; Kumada K; Fujiwara M; Fujiwara M
Biochem Pharmacol; 1986 Dec; 35(24):4473-7. PubMed ID: 3098251
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of histamine release from human basophils in vitro by calmodulin antagonists.
Marone G; Columbo M; Poto S; Condorelli M
Clin Immunol Immunopathol; 1983 Sep; 28(3):334-40. PubMed ID: 6192958
[TBL] [Abstract][Full Text] [Related]
15. Direct interaction of calmodulin antagonists with Ca2+/calmodulin-dependent cyclic nucleotide phosphodiesterase.
Itoh H; Hidaka H
J Biochem; 1984 Dec; 96(6):1721-6. PubMed ID: 6099352
[TBL] [Abstract][Full Text] [Related]
16. Possible role of calmodulin in the control of histamine release from human basophil leukocytes.
Marone G; Columbo M; Poto S; Giugliano R; Condorelli M
Life Sci; 1986 Sep; 39(10):911-22. PubMed ID: 2427907
[TBL] [Abstract][Full Text] [Related]
17. Calmodulin antagonists inhibit secretion in Paramecium.
Garofalo RS; Gilligan DM; Satir BH
J Cell Biol; 1983 Apr; 96(4):1072-81. PubMed ID: 6403556
[TBL] [Abstract][Full Text] [Related]
18. Interaction of the dihydropyridine calcium antagonist, CD-349, with calmodulin.
Tanaka M; Muramatsu M; Aihara H; Otomo S
Biochem Pharmacol; 1990 Sep; 40(5):991-6. PubMed ID: 2167684
[TBL] [Abstract][Full Text] [Related]
19. Interaction of trifluoperazine with Tetrahymena calmodulin. A 19F NMR study.
Shimizu T; Hatano M; Muto Y; Nozawa Y
FEBS Lett; 1984 Jan; 166(2):373-7. PubMed ID: 6420195
[TBL] [Abstract][Full Text] [Related]
20. Two types of calcium-dependent protein phosphorylations modulated by calmodulin antagonists. Naphthalenesulfonamide derivatives.
Tanaka T; Ohmura T; Yamakado T; Hidaka H
Mol Pharmacol; 1982 Sep; 22(2):408-12. PubMed ID: 6897280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
